Aurobindo Pharma Ltd has clarified regarding Unit-7 facility inspection by USFDA and issue of Form 483 with 7 observations. These observations have no impact on the existing business with respect to the operations and revenues.
The Company will be sending responses to the observations within the stipulated time to the regulatory authority.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.438.1 as compared to the previous close of Rs. 465.15. The total number of shares traded during the day was 880378 in over 14683 trades.
The stock hit an intraday high of Rs. 466 and intraday low of 435. The net turnover during the day was Rs. 392014383.